Leukemia Research
Volume 26, Issue 3 , Pages 301-310 , March 2002

Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine

Received 24 February 2001 ,Accepted 16 July 2001.

References 

  1. Klostergaard J, Auzenne E, Leroux E. Characterization of cytotoxicity induced by sphingolipids in multidrug-resistant leukemia cells. Leukemia Res. 1998;22(11):1049
  2. Shirahama T, Sweeney EA, Sakakura C, Singhal AK, Nishiyama K, Akiyama S, et al.  In vitro and in vivo induction of apoptosis by sphingosine and N,N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells. Clin. Cancer Res. 1997;3(2):257
  3. Lavie Y, Jones RC, Giuliano AE, Cabot MC. Accumulation of novel sphingoid bases in multidrug-resistant (MDR) human breast cancer MCF-7 cells. Proc Annu Meet Am Assoc Cancer Res 1996;37(A2247) [Meeting abstract].
  4. Merrill AH, et al.  Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 1997;142(1):208; Review
  5. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 1981;50(733).
  6. Hannun YA, Bell RM. Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science. 1987;235(4789):670
  7. Hannun YA, Bell RM. Regulation of protein kinase C by sphingosine and lysosphingolipids. Clin. Chim. Acta. 1989;185(3):333
  8. Merrill AH. Cell regulation by sphingosine and more complex sphingolipids. J. Bioenerg. Biomembr. 1991;23(1):83
  9. Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Zakeri Z. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. The ceramide amide group is not required for apoptosis. Eur. J. Biochem. 1996;236(2):729
  10. Sakakura C, Sweeney EA, Shirahama T, Hakomori S, Igarashi Y. Suppression of bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation. FEBS Lett. 1996;379(2):177
  11. Sweeney EA, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S, et al.  Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer. 1996;66(3):358
  12. Auzenne E, Leroux ME, Hu M, Pollock RE, Feig B, Klostergaard J. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro. Melanoma Res. 1998;8(3):227
  13. Edsall LC, Van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S. N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry. 1998;37(37):12892
  14. Consoli U, Priebe W, Ling YH, Mahadevia R, Griffin M, Zhao S, et al.  The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Blood. 1996;88(2):633
  15. Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991;3(7):207
  16. Merrill AH, et al.  Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 1997;142(1):208
  17. Hannun YA. Sphingolipid second messengers: tumor suppressor lipids. Adv. Exp. Med. Biol. 1997;400A(305) [Review].
  18. Spiegel S, Merrill AH. Sphingolipid metabolism and cell growth regulation. Fed. Am. Soc. Exp. Biol. J. 1996;10(12):1388
  19. Pushkareva M, Obeid LM, Hannun YA. Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today. 1995;16(6):294; see comments
  20. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 1995;55(3):691
  21. Obeid LM, Hannun YA. Ceramide: a stress signal and mediator of growth suppression and apoptosis. J. Cell. Biochem. 1995;58(2):191
  22. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 1995;20(2):73
  23. Brugg B, Michel PP, Agid Y, Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 1996;66(2):733
  24. Chmura SJ, Nodzenski E, Crane MA, Virudachalam S, Hallahan DE, Weichselbaum RR, Quintans J. Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. Adv Exp Med Biol 1996;406(39).
  25. Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation. J. Immunol. 1996;157(1):297
  26. Jaffrezou JP, et al.  Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. Eur. Mol. Biol. Org. J. 1996;15(10):2417
  27. Jarvis WD, Fornari FA, Traylor RS, Martin HA, Kramer LB, Erukulla RK, et al.  Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 1996;271(14):8275
  28. Haimovitz-Friedman A, Kolesnick RN, Fuks Z. Ceramide signaling in apoptosis. Br. Med. Bull. 1997;53(3):539
  29. Hannun YA, Obeid LM. Mechanisms of ceramide-mediated apoptosis. Adv. Exp. Med. Biol. 1997;407(145).
  30. Geley S, Hartmann BL, Kofler R. Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA. FEBS Lett. 1997;400(1):15
  31. Shatrov VA, Lehmann V, Chouaib S. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells. Biochem. Biophys. Res. Commun. 1997;234(1):121
  32. Sakano S, Takemura H, Yamada K, Imoto K, Kaneko M, Ohshika H. Ca2+ mobilizing action of sphingosine in Jurkat human leukemia T cells. Evidence that sphingosine releases Ca2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate. J. Biol. Chem. 1996;271(19):11148
  33. Sweeney EA, Inokuchi J, Igarashi Y. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett. 1998;425(1):61
  34. Shin Y, Daly JW, Choi OH. Diverse effects of sphingosine on calcium mobilization and influx in differentiated HL-60 cells. Cell Calcium. 2000;27(5):269
  35. Hung WC, Chang HC, Chuang LY. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 1999;338(Pt 1):161
  36. Hung WC, Chuang LY. Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem. Biophys. Res. Commun. 1996;229(1):11
  37. Brindley DN, Abousalham A, Kikuchi Y, Wang CN, Waggoner DW. “Cross talk” between the bioactive glycerolipids and sphingolipids in signal transduction. Biochem. Cell Biol. 1996;74(4):469
  38. Muller G, et al.  Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. Eur. Mol. Biol. Org. J. 1998;17(3):732
  39. Ragg SJ, Kaga S, Berg KA, Ochi A. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J. Immunol. 1998;161(3):1390
  40. Hernandez M, Barrero MJ, Crespo MS, Nieto ML. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C[gamma] and a G[alpha]i protein. J. Neurochem. October. 2000;75(4):1575
  41. Burow ME, et al.  Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J. Biological Chem. 2000;275(13):9628
  42. Pallis M, Russell N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin–ceramide apoptotic pathway. Blood. 2000;95(9):2897
  43. Lucci A, Han TY, Liu YY, Giuliano AE, Cabot MC. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells. Cancer. 1999;86(2):300
  44. Lucci A, Giuliano AE, Han TY, Dinur T, Liu YY, Senchenkov A, et al.  Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. Int. J. Oncol. 1999;15(3):535
  45. Lavie Y, Cao H, Bursten SL, Giuliano AE, Cabot MC. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biological Chem. 1996;271(32):19530
  46. Sautin Y, Takamura N, Shklyaev S, Nagayama Y, Ohtsuru A, Namba H, et al.  Ceramide-induced apoptosis of human thyroid cancer cells resistant to apoptosis by irradiation. Thyroid. 2000;10(9):733
  47. Nava VE, Cuvillier O, Edsall LC, Kimura K, Milstien S, Gelmann EP, et al.  Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 2000;60(16):4468
  48. Lin X, Fuks Z, Kolesnick R. Ceramide mediates radiation-induced death of endothelium. Crit. Care Med. 2000;28(Suppl 4):N87
  49. Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 1997;57(7):1270
  50. Quintans J, Kilkus J, McShan CL, Gottschalk AR, Dawson G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem. Biophys. Res. Commun. 1994;202(2):710
  51. Michael JM, Lavin MF, Watters DJ. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 1997;57(16):3600
  52. Jarvis WD, Grant S. Protein kinase C targeting in antineoplastic treatment strategies. Invest. New Drugs. 1999;17(3):227
  53. Schwartz GK, et al.  Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J. Natl. Cancer Inst. 1995;87(18):1394
  54. Sachs CW, Safa AR, Harrison SD, Fine RL. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J. Biological Chem. 1995;270(44):26639
  55. Amin HM, Ergin M, Denning MF, Quevedo ME, Alkan S. Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia. Br. J. Haematol. September. 2000;110(3-I):552
  56. Kedderis LB, Bozigian HP, Kleeman JM, Hall RL, Palmer TE, Harrison SD, et al.  Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents. Fundamental Appl. Toxicol. 1995;25(2):201
  57. Mehta S, Blackinton D, Omar I, Kouttab N, Myrick D, Klostergaard J, et al.  Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother. Pharmacol. 2000;46(2):85
  58. Schwartz GK, et al.  A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin. Clin. Cancer Res. 1997;3(4):537
  59. Nakabo Y, Pabst MJ. Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C. Jpn. J. Cancer Res. 1998;89(5):548

PII: S0145-2126(01)00129-1

Leukemia Research
Volume 26, Issue 3 , Pages 301-310 , March 2002

Article Tools

* Image Usage & Resolution